Chet Bohac, PharmD, MD, MSc

Rare Disease / Clinical Research

Executive Medical Director, Clinical Development, Xencor, Inc.

PI on 1 trial

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

Primary effusion lymphoma
Primary mediastinal large B-cell lymphoma
T-cell prolymphocytic leukemia
Lower limb hypertrophy
ALK-positive large B-cell lymphoma
Hairy cell leukemia variant
B-cell prolymphocytic leukemia
T-cell/histiocyte rich large B cell lymphoma
Intravascular large B-cell lymphoma
Kaposi sarcoma
Diffuse large B-cell lymphoma with chronic inflammation
Lymphomatoid granulomatosis

Clinical trials (1)

NCT02924402

Verify independently

ClinicalTrials.gov PI search for Chet Bohac, PharmD, MD, MSc

Other specialists for Primary effusion lymphoma

Peers ranked by clinical-trial PI role, publications, and verification quality.

Richard F. Little, MD
NCI - HIV and AIDS Malignancy Branch
Robert Yarchoan, M.D.
National Cancer Institute (NCI)
Maryland
Ramya M Ramaswami, M.D.
National Cancer Institute (NCI)
Maryland
Pei Wang, PhD
Eureka Therapeutics Inc.
Wyndham H Wilson, M.D., MD, PhD
National Cancer Institute (NCI)
MD
Stephen M Ansell, M.D
Dana-Farber - Harvard Cancer Center LAO
MN
Ramya Ramaswami, M.D., MD MPH
National Cancer Institute (NCI)
MD
Frank G Basile, M.D., MD
Schrodinger Inc.
RI

See all specialists for Primary effusion lymphoma →

← Back to specialists directory